Mutational landscape in cutaneous melanoma
Open Access
- 22 October 2026
- journal article
- Published by Elsevier in EJC Skin Cancer
- Vol. 4
Abstract
No abstract availableThis publication has 133 references indexed in Scilit:
- RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma‐like mesenchymal tumorsThe Journal of Pathology, 2024
- ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesisCancer Cell, 2024
- Spitz tumor with RAF1 fusion: A report of 3 casesAnnals of Diagnostic Pathology, 2023
- Effect and biomarker of immune checkpoint blockade therapy for ARID1A deficiency cancersBiomedicine & Pharmacotherapy, 2020
- UTX Mutations in Human CancerCancer Cell, 2019
- KIT as an Oncogenic Driver in Melanoma: An Update on Clinical DevelopmentAmerican Journal of Clinical Dermatology, 2019
- Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 ActivationCancer Cell, 2018
- NF1‐mutated melanoma tumors harbor distinct clinical and biological characteristicsMolecular Oncology, 2017
- The role of CCND1 alterations during the progression of cutaneous malignant melanomaTumor Biology, 2012
- Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activityInternational Journal of Cancer, 2002